Arcturus Therapeutics Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Arcturus Therapeutics Holdings Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
Israel
Fiscal year end
December
Ticker symbol
ARCT
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001768224

Board of directors

Chief executives

Joseph E. Payne · President and CEO
Dates unknown

Board connections

4 of this board's directors also sit on 7 other boards. 7 are in the same sector.

Network of Arcturus Therapeutics Holdings Inc.'s board connections Vaxcyte Inc. Vaxcyte Inc. AnaptysBio Inc. AnaptysBio Inc. Evolus Inc. Evolus Inc. First Tracks Biotherapeutics Inc. First Tracks Biotherap... Immix Biopharma Inc. Immix Biopharma Inc. ResMed Inc. ResMed Inc. TransCode Therapeutics Inc. TransCode Therapeutics... John Markels John Markels Magda Marquet Magda Marquet Moncef Slaoui Moncef Slaoui Peter C. Farrell Peter C. Farrell Arcturus Therapeutics Hold...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 15, 2025 Andy Sassine Director, Officer (Chief Financial Officer) Open-market purchase −1,238 $16.56 $20,501
Oct 15, 2024 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −12,000 $20.76 $249,120
Jun 14, 2024 Jing L. Marantz Director Option exercise +3,131 — —
Jun 14, 2024 Edward W. Holmes Director Option exercise +3,131 — —
Jun 14, 2024 John Markels Director Option exercise +3,131 — —
Jun 14, 2024 Magda Marquet Director Option exercise +3,131 — —
Jun 14, 2024 James F. Barlow Director Option exercise +3,131 — —
Jun 14, 2024 Peter C. Farrell Director Option exercise +3,131 — —
Jun 12, 2024 Andy Sassine Director, Officer (Chief Financial Officer) Open-market sale −50,000 $32.03 $1,601,500
Jun 5, 2024 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −114 $45.00 $5,130
Jun 3, 2024 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −26,000 $40.01 $1,040,260
Mar 25, 2024 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −17,435 $35.02 $610,574
Mar 19, 2024 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −8,565 $35.01 $299,861
Nov 1, 2023 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −5,000 $18.72 $93,600
Oct 2, 2023 Chivukula Pad Officer (Chief Scientific Officer & COO) Open-market sale −5,000 $25.61 $128,050

Organizations in the same sector, closest in location and size first.

Questions about Arcturus Therapeutics Holdings Inc.

Who is the CEO of Arcturus Therapeutics Holdings Inc.?

Joseph E. Payne is Arcturus Therapeutics Holdings Inc.'s President and CEO.

How many directors are on Arcturus Therapeutics Holdings Inc.'s board?

Arcturus Therapeutics Holdings Inc.'s board has 9 directors: Andy Sassine, Edward W. Holmes, James F. Barlow, Jing L. Marantz, John Markels, Joseph E. Payne, Magda Marquet, Moncef Slaoui and Peter C. Farrell.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="arcturus-therapeutics-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.